Connect Biopharma

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.

About CNTB

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.

CEO

Barry D. Quart

CEOBarry D. Quart

Employees

Employees62

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

2015

Founded2015

Employees

Employees62

CNTB Key Statistics

Market cap

45.11M

Market cap45.11M

Price-Earnings ratio

-2.89

Price-Earnings ratio-2.89

Dividend yield

—

Dividend yield—

Average volume

80.28K

Average volume80.28K

High today

$0.86

High today$0.86

Low today

$0.7819

Low today$0.7819

Open price

$0.86

Open price$0.86

Volume

78.48K

Volume78.48K

52 Week high

$2.07

52 Week high$2.07

52 Week low

$0.51

52 Week low$0.51

Connect Biopharma

Why Robinhood?

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. Show more

CNTB Key Statistics

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease.